Kwality Pharmaceuticals Management
Management criteria checks 3/4
Kwality Pharmaceuticals' CEO is Ramesh Arora, appointed in Jan 2016, has a tenure of 8.92 years. directly owns 26.9% of the company’s shares, worth ₹2.50B. The average tenure of the management team and the board of directors is 8.9 years and 9 years respectively.
Key information
Ramesh Arora
Chief executive officer
₹6.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.9yrs |
| CEO ownership | 26.9% |
| Management average tenure | 8.9yrs |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
CEO
Ramesh Arora (70 yo)
8.9yrs
Tenure
₹6,000,000
Compensation
Mr. Ramesh Arora has been the Managing Director and Executive Director of Kwality Pharmaceuticals Limited since January 16, 2016 and May 4, 1983 respectively. Mr. Arora has more than 3 decades of experienc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 8.9yrs | ₹6.00m | 26.9% ₹ 2.5b | |
| CFO & Whole Time Director | 8.9yrs | ₹4.20m | 11.95% ₹ 1.1b | |
| Whole Time Director | no data | ₹6.00m | 13.59% ₹ 1.3b | |
| Whole Time Director | no data | ₹2.40m | 1.31% ₹ 121.6m | |
| Whole Time Director | no data | ₹2.40m | 1.07% ₹ 100.0m | |
| Company Secretary & Compliance Officer | 5.4yrs | no data | no data | |
| Chief Domestic Sales Officer | no data | no data | no data |
8.9yrs
Average Tenure
55yo
Average Age
Experienced Management: 539997's management team is seasoned and experienced (8.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 41.6yrs | ₹6.00m | 26.9% ₹ 2.5b | |
| CFO & Whole Time Director | 9.2yrs | ₹4.20m | 11.95% ₹ 1.1b | |
| Whole Time Director | 29.3yrs | ₹6.00m | 13.59% ₹ 1.3b | |
| Whole Time Director | 14.2yrs | ₹2.40m | 1.31% ₹ 121.6m | |
| Whole Time Director | 14.2yrs | ₹2.40m | 1.07% ₹ 100.0m | |
| Non-Executive Independent Director | 8.8yrs | ₹180.00k | no data | |
| Non-Executive Independent Director | 8.8yrs | ₹108.00k | 0.029% ₹ 2.7m | |
| Non-Executive Independent Director | 8.8yrs | ₹20.00k | no data | |
| Independent Director | 3.9yrs | ₹20.00k | no data | |
| Non-Executive & Independent Director | 1.8yrs | ₹7.00k | no data |
9.0yrs
Average Tenure
52yo
Average Age
Experienced Board: 539997's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 17:31 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kwality Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|